Professor Paolo Bonanni (Florence, Italy) illustrates a current debate in the European medical community: whether introducing or not the universal vaccination against varicella in all European Countries. On this purpose he also explains the differences of using the quadrivalent MMRV (measles-mumps-rubella-varicella) compared to the MMR+V.